Radiofrequency Electrosurgical Unit segmentation by application reveals distinct demand drivers across surgical specialties. General surgery accounts for the largest share, roughly 35 % of total revenue, driven by high procedure volumes in laparoscopic coagulation, tissue dissection, and vessel sealing. Gynecology follows with an estimated 20 % contribution, reflecting widespread adoption of RF devices for hysterectomy, myomectomy, and endometrial ablation where precise thermal control reduces intra‑operative bleeding. Dermatology represents about 15 % of the market, primarily for cutaneous lesion removal, skin resurfacing, and vascular lesion treatment, where RF offers controlled depth of penetration. Ear‑nose‑throat (ENT) applications, at 12 %, are anchored in tonsillectomy, sinus surgery, and airway reconstruction, leveraging the unit’s ability to achieve hemostasis in confined spaces. Urology contributes roughly 10 % through procedures such as transurethral resection of the prostate and renal tumor ablation. The residual 8 % comprises niche areas—orthopedics, neurosurgery, and veterinary medicine—where RF technology is emerging. This application‑driven taxonomy clarifies how each sub‑segment underpins the overall market size.